Pointerra=the early Promedicus

If 3DP implements its business plan well as I expect them to do, I believe they can emulate Promedicus PME strong long term price appreciation (see below link). Both 3DP and PME solve the same problem - the difficulty in managing large data sets, in PME's case its health imaging (scans etc) while in 3DP's case, 3D data sets (geospatial). 3DP has more verticals than PME. We have not even got to the $30m mcap mark for 3DP and a huge potential ahead for significant long term price appreciation! 3DP has yet to attract instos attention yet, so stay tuned and lock your shares up. GLTAH!

https://www.barchart.com/stocks/quo...&sym=PME.AX&grid=1&height=500&studyheight=100